Use of a prostacyclin analogue in cholesterol crystal embolism.
The prognosis of cholesterol embolism is often poor, and no treatment is presently available. We report the use of a stable prostacyclin analogue in treating cholesterol embolism in a diabetic patient with arteriopathy. As a sole therapy, it improved cutaneous manifestations and pain, in parallel with an increased transcutaneous oxymetry. We think that prostacyclin analogues are novel candidates for the treatment of cholesterol embolism.
Radauceanu
A
A
Department of Metabolic Diseases, CHU Lapeyronie, Montpellier, France.
Avignon
A
A
Ribstein
J
J
Monnier
L
L
D000368:Aged; D003460:Crystallization; D003924:Diabetes Mellitus, Type 2 / Q000150:complications*; D003925:Diabetic Angiopathies / Q000150:complications; D017700:Embolism, Cholesterol / Q000175:diagnosis / Q000188:drug therapy* / Q000209:etiology; D006801:Humans; D016285:Iloprost / Q000008:administration & dosage / Q000627:therapeutic use*; D008297:Male
D016285:Iloprost